These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31444140)

  • 1. Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure.
    Toyoda S; Haruyama A; Inami S; Arikawa T; Saito F; Watanabe R; Sakuma M; Abe S; Nakajima T; Tanaka A; Node K; Inoue T
    J Cardiol; 2020 Feb; 75(2):140-147. PubMed ID: 31444140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure.
    Toyoda S; Haruyama A; Inami S; Amano H; Arikawa T; Sakuma M; Abe S; Tanaka A; Node K; Inoue T
    Int J Cardiol; 2017 Jan; 226():71-76. PubMed ID: 27792991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
    Kovacić D; Marinsek M; Gobec L; Lainscak M; Podbregar M
    Clin Res Cardiol; 2008 Jan; 97(1):24-31. PubMed ID: 17694376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
    Chin BS; Langford NJ; Nuttall SL; Gibbs CR; Blann AD; Lip GY
    Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.
    Düngen HD; Apostolović S; Inkrot S; Tahirović E; Krackhardt F; Pavlović M; Putniković B; Lainscak M; Gelbrich G; Edelmann F; Wachter R; Eschenhagen T; Waagstein F; Follath F; Rauchhaus M; Haverkamp W; Osterziel KJ; Dietz R;
    Clin Res Cardiol; 2008 Sep; 97(9):578-86. PubMed ID: 18542839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
    Podbregar M; Voga G
    J Card Fail; 2002 Dec; 8(6):369-78. PubMed ID: 12528088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability, Efficacy, and Safety of Bisoprolol vs. Carvedilol in Japanese Patients With Heart Failure and Reduced Ejection Fraction　- The CIBIS-J Trial.
    Tsutsui H; Momomura SI; Masuyama T; Saito Y; Komuro I; Murohara T; Kinugawa S;
    Circ J; 2019 May; 83(6):1269-1277. PubMed ID: 30956267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.
    Konishi M; Haraguchi G; Kimura S; Inagaki H; Kawabata M; Hachiya H; Hirao K; Isobe M
    Circ J; 2010 Jun; 74(6):1127-34. PubMed ID: 20354334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
    Sessa M; Mascolo A; Rasmussen DB; Kragholm K; Jensen MT; Sportiello L; Rafaniello C; Tari GM; Pagliaro C; Andersen M; Rossi F; Capuano A
    Sci Rep; 2019 Aug; 9(1):11465. PubMed ID: 31391573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
    Díez Manglano J
    Rev Clin Esp; 2005 Apr; 205(4):149-56. PubMed ID: 15860185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP; Lou M; Deng B; Song HM; Wang HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The double anaerobic threshold in heart failure.
    Rovai S; Contini M; Sciomer S; Vignati C; Agostoni P
    Int J Cardiol; 2022 Apr; 353():68-70. PubMed ID: 35090987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.